ICMR Designs Kit For Omicron Detection

NEW DELHI : The Indian Council of Medical Research (ICMR) has designed a diagnostic kit for detection of Omicron variant of the coronavirus and has invited expression of interest (EoI) from in vitro diagnostics (IVD) kit manufacturers for undertaking transfer of technology for its development and commercialisation.

The ICMR-Regional Medical Research Centre, NE, Dibrugarh, has developed a novel technology — real-time RT-PCR assay for detection of Omicron (B.1.1.529) variant of SARS-CoV2 and a kit for the same.

“ICMR is the owner of the said technology, including any underlying intellectual property(ies) and commercialisation rights. ICMR is lawfully entitled to enter into any form of non-exclusive license agreements with selected manufacturer/manufacturers, including transfer of technology through suitable agreement to any other interested manufacturers,” the invitation of EoI document said.

“ICMR invites EOI through email from experienced IVD kit manufacturers for undertaking transfer of technology for development and commercialisation of SARS-CoV-2 Omicron (B.1.1.529) real time RT-PCR assay through a novel diagnostic kit,” the invitation of EoI said.

  • Related Posts

    Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

    Fujifilm India, a leading healthcare technology company, has expanded its ELUXEO 8000 endoscopy portfolio with the launch of its next-generation therapeutic gastroscopes at Endocon 2026. India is witnessing a growing…

    Draft bill proposes powers for DIs to inspect online pharmacy office premises

    Amidst years of uncertainty over the regulation of e-pharmacies in the country, the draft Drugs, Medical Devices and Cosmetics Bill, 2026, proposes to bestow the powers with the drugs inspectors…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

    Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

    Draft bill proposes powers for DIs to inspect online pharmacy office premises

    Draft bill proposes powers for DIs to inspect online pharmacy office premises

    Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

    Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

    FDA cancels drug sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit

    FDA cancels drug sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit

    Delhi DCA mandates digital tracking for controlled substances on new DMS portal

    Delhi DCA mandates digital tracking for controlled substances on new DMS portal

    How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?

    How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?